SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-021213
Filing Date
2024-03-11
Accepted
2024-03-11 07:03:16
Documents
19
Period of Report
2024-03-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201449-8k_180life.htm   iXBRL 8-K 53121
2 OFFER LETTER BETWEEN 180 LIFE SCIENCE CORP. AND OMAR JIMENEZ (DIRECTOR) DATED MA ea020144901ex10-1_180life.htm EX-10.1 21577
3 OFFER LETTER BETWEEN 180 LIFE SCIENCE CORP. AND RYAN L. SMITH (DIRECTOR) DATED M ea020144901ex10-2_180life.htm EX-10.2 20220
4 GRAPHIC ex10-1_001.jpg GRAPHIC 2937
5 GRAPHIC ex10-2_001.jpg GRAPHIC 2937
  Complete submission text file 0001213900-24-021213.txt   338262

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE atnf-20240307.xsd EX-101.SCH 3799
7 XBRL DEFINITION FILE atnf-20240307_def.xml EX-101.DEF 26637
8 XBRL LABEL FILE atnf-20240307_lab.xml EX-101.LAB 36680
9 XBRL PRESENTATION FILE atnf-20240307_pre.xml EX-101.PRE 25261
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0201449-8k_180life_htm.xml XML 5729
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 24736524
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)